Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?

Affiliations

¹ Department of Hepatology and Gastroenterology, Liver Unit, Niguarda Hospital, Milan, Italy. Electronic address: claudio.zavaglia@ospedaleniguarda.it.
² Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy; International Center for Digestive Health, University of Milan-Bicocca, Milan, Italy.
³ Department of Hepatology and Gastroenterology, Liver Unit, Niguarda Hospital, Milan, Italy.
⁴ Department of Hepatology and Gastroenterology, Liver Unit, Niguarda Hospital, Milan, Italy; International Center for Digestive Health, University of Milan-Bicocca, Milan, Italy.

Comment

Claudio Zavaglia et al. J Hepatol. 2017 Jan.

. 2017 Jan;66(1):236-237.

doi: 10.1016/j.jhep.2016.08.016. Epub 2016 Aug 31.

¹ Department of Hepatology and Gastroenterology, Liver Unit, Niguarda Hospital, Milan, Italy. Electronic address: claudio.zavaglia@ospedaleniguarda.it.
² Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy; International Center for Digestive Health, University of Milan-Bicocca, Milan, Italy.
³ Department of Hepatology and Gastroenterology, Liver Unit, Niguarda Hospital, Milan, Italy.
⁴ Department of Hepatology and Gastroenterology, Liver Unit, Niguarda Hospital, Milan, Italy; International Center for Digestive Health, University of Milan-Bicocca, Milan, Italy.

No abstract available

Comment on

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy.
Reig M, Mariño Z, Perelló C, Iñarrairaegui M, Ribeiro A, Lens S, Díaz A, Vilana R, Darnell A, Varela M, Sangro B, Calleja JL, Forns X, Bruix J. Reig M, et al. J Hepatol. 2016 Oct;65(4):719-726. doi: 10.1016/j.jhep.2016.04.008. Epub 2016 Apr 13. J Hepatol. 2016. PMID: 27084592